• Home
  • Syngene International Ltd.

Syngene International Ltd.

About Syngene International Ltd.

Syngene International Ltd. (BSE: 539268, NSE: SYNGENE, ISIN: INE398R01022) is an integrated contract research, development and manufacturing organisation providing scientific services -- from early discovery to commercial supply. Our innovative capabilities for novel molecular entities (NMEs) cater to pharma, biotech, nutrition, animal health, consumer goods and speciality chemical companies

Read more Show less
Sales Markets
Show more Show less
Categories
more categories Show less
  • IN
  • 2015
    On CPHI since
  • 5000+
    Employees
Company types
Contract Service
View company profile
Contact info
  • +91 80 2808 2808
  • Website
  • Biocon Park , Plot 2&3,, Bommasandra Industrial Estate - Phase-IV, Bommasandra-Jigani Link Road,, 560 099, Bangalore, India
Show contact info Hide contact info
Meet us at

CPHI Milan 2024

Fiera Milano, Italy
08 Oct 2024 - 10 Oct 2024
View Exhibitor Profile

Products from Syngene International Ltd. (5)

  • Small & large molecule Discovery & Development

    Product Small & large molecule Discovery & Development

    Discovery Chemistry, Discovery Biology, Integrated Drug Discovery
  • Integrated Drug Substance-Drug Product development

    Product Integrated Drug Substance-Drug Product development

    Process R&D, Custom manufacturing, formulation development, Clinical supplies, safety assessment
  • Clinical supplies

    Product Clinical supplies

    Syngene International Ltd. provides wide range of services which includes clinical supplies. It belongs to formulation development services category. It includes scale range - 0.1 kg to 50 kg, packaging - bottles and blister packing. Contact us for more information.
  • Antibody Drug Conjugates

    Product Antibody Drug Conjugates

    Syngene’s Antibody Drug Conjugate (ADC) unit brings together an array of multidisciplinary capabilities in antibody generation, linker and payload chemistry, conjugation chemistry, in vitro and in vivo oncology in an integrated platform.
  • Oligonucleotide Synthesis

    Product Oligonucleotide Synthesis

    Syngene’s Oligonucleotide capacity & services ranges from development to cGMP manufacturing of chemically synthesized high quality modified and non-modified custom Oligonucleotide (DNA/RNA), siRNA (single & double stranded, miRNA (modified and non-modified), Antisense, fast delivery of Oligonucleot...

Syngene International Ltd. Resources (2)